Both in Biotechnology
Kyverna Therapeutics vs C4 Therapeutics
Over the past year KYTX returned +13.3% and CCCC returned +50.0%; their daily moves had a correlation of 0.36.
KYTX +13.3% CCCC +50.0%Growth of $1, one year, split-adjusted
| Metric | KYTX | CCCC |
|---|---|---|
| Price | $6.80 | $3.33 |
| Market cap | $420.5M | $409.7M |
| Today | −0.58% | +6.39% |
| 1 month | −19.8% | −10.2% |
| 6 months | −21.2% | +26.6% |
| Year to date | −27.7% | +74.3% |
| 1 year | +14.5% | +49.3% |
| Revenue growth (YoY) | — | +2.8% |
| Gross margin | — | 100.0% |
| Net margin | — | −355.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 11.7× |
| Net cash | $174.4M | $253.7M |
| Dividend yield | — | — |
| Volatility (60d) | 64.8% | 54.5% |
| Short % of float | 23.8% | 40.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).